James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $569.63 ($5.7M) on 2026-04-23, disclosed to the SEC on 2026-04-24.
Scheduled sale ($5.7M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $575.85 | 364 | $210K | 3.7% |
| 2 | $569.63 | 280 | $159K | 2.8% |
| 3 | $570.82 | 1,079 | $616K | 10.8% |
| 4 | $571.64 | 3,325 | $1.9M | 33.2% |
| 5 | $572.66 | 3,976 | $2.3M | 39.8% |
| 6 | $573.51 | 321 |
| $184K |
| 3.2% |
| 7 | $574.79 | 535 | $308K | 5.4% |
| 8 | $576.62 | 120 | $69K | 1.2% |
| Total | $572.34 avg | 10,000 | $5.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |